Search by Drug Name or NDC

    NDC 65162-0844-06 Capecitabine 500 mg/1 Details

    Capecitabine 500 mg/1

    Capecitabine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is CAPECITABINE.

    Product Information

    NDC 65162-0844
    Product ID 65162-844_1a486e69-519c-4bd1-b777-013a1b5b2793
    Associated GPIs 21300005000350
    GCN Sequence Number 039781
    GCN Sequence Number Description capecitabine TABLET 500 MG ORAL
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 31612
    HICL Sequence Number 018385
    HICL Sequence Number Description CAPECITABINE
    Brand/Generic Generic
    Proprietary Name Capecitabine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Capecitabine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 500
    Active Ingredient Units mg/1
    Substance Name CAPECITABINE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA204741
    Listing Certified Through n/a

    Package

    NDC 65162-0844-06 (65162084406)

    NDC Package Code 65162-844-06
    Billing NDC 65162084406
    Package 60 TABLET in 1 BOTTLE (65162-844-06)
    Marketing Start Date 2017-03-10
    NDC Exclude Flag N
    Pricing Information N/A